Danshensu alleviates bleomycin-induced pulmonary fibrosis by inhibiting lung fibroblast-to-myofibroblast transition via the MEK/ERK signaling pathway

Pulmonary fibrosis (PF) is a chronic pulmonary interstitial disease, and its pathological process is closely related to fibroblast–myofibroblast differentiation. Danshensu (DSS) has been reported to exert an anti-fibrotic effect in heart and liver. However, it is unknown whether DSS has an equally a...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Huaman, Zhang, Xinyue, Shao, Yumeng, Lin, Xuehong, Dong, Feng, Liu, Xue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806824/
https://www.ncbi.nlm.nih.gov/pubmed/34187349
http://dx.doi.org/10.1080/21655979.2021.1944020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806824/
https://www.ncbi.nlm.nih.gov/pubmed/34187349
http://dx.doi.org/10.1080/21655979.2021.1944020

Ejemplares similares